Publications by authors named "Ian Cromwell"

Claim this Profile
S
SurvdigitizeR: an algorithm for automated survival curve digitization.
Jasper Zhongyuan Zhang, Juan David Rios, Tilemanchos Pechlivanoglou, Alan Yang, Qiyue Zhang, Ian Cromwell

BMC Med Res Methodol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60.
Dean A Regier, Brandon Chan, Sarah Costa, David W Scott, Christian Steidl, Ian Cromwell

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
Ian Cromwell, Laurie W Smith, Kim van der Hoek, Lindsay Hedden, Andrew J Coldman

Cancer Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment.
Shan Jiang, Aslam H Anis, Ian Cromwell, Tima Mohammadi, Kasmintan A Schrader

Genet Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.
Ian Cromwell, Dean A Regier, Stuart J Peacock, Catherine F Poh

Oncologist· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Real-world' health care priority setting using explicit decision criteria: a systematic review of the literature.
Ian Cromwell, Stuart J Peacock, Craig Mitton

BMC Health Serv Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.
Sonya Cressman, Stephen Lam, Martin C Tammemagi, William K Evans, Natasha B Leighl, Ian Cromwell

J Thorac Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis.
Ian Cromwell, Kimberly van der Hoek, Suzanne C Malfair Taylor, Barbara Melosky, Stuart Peacock

Lung Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis.
Ian Cromwell, Kimberly van der Hoek, Barbara Melosky, Stuart Peacock

J Thorac Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis